Migenix Licenses GenomeQuest's Sequence Searcher | GenomeWeb
NEW YORK (GenomeWeb News) — GenomeQuest said today it is licensing its sequence search technology to Migenix, a Vancouver, BC-based drug developer. 
The company, formerly known as Gene-IT, said Migenix will use its GenomeQuest product in its clinical programs, which include drug candidates for hepatitis C, catheter-related infections, and dermatological diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.